Avita Medical Inc.
ASX: AVH
Avita Accelerates Revenue Growth as Multi-Product Strategy Targets $3.5B Market Opportunity
(Source: TradingView) 3-Month Performance Profile of AVH compared to the S&P/ASX 200 (XJO).
Avita Medical reported Q1 FY25 revenue of $29.5 million, reflecting a strong 74.62% year-over-year growth, continuing its upward trajectory from previous quarters. This acceleration h
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
